CAS 251647-50-4

5′-O-[Bis(4-methoxyphenyl)phenylmethyl]-2′-O-(2-methoxyethyl)-N-(2-methyl-1-oxopropyl)guanosine

Description:

5′-O-[Bis(4-methoxyphenyl)phenylmethyl]-2′-O-(2-methoxyethyl)-N-(2-methyl-1-oxopropyl)guanosine is a complex organic compound that belongs to the class of modified nucleosides. Its structure features a guanosine backbone, which is a purine nucleoside composed of a guanine base attached to a ribose sugar. The compound is characterized by multiple substituents, including a bis(4-methoxyphenyl)phenylmethyl group at the 5′ position and a 2-methoxyethyl group at the 2′ position, which enhance its solubility and potentially its biological activity. The N-(2-methyl-1-oxopropyl) modification at the nitrogen position contributes to its unique properties. This compound may exhibit interesting pharmacological activities, making it a subject of interest in medicinal chemistry and drug development. Its specific interactions and mechanisms of action would require further investigation through experimental studies. As with many modified nucleosides, it may also have implications in the fields of molecular biology and biochemistry, particularly in the context of nucleic acid research and therapeutic applications.

Formula: C₃₈H₄₃N₅O₉

InChI: InChI=1S/C38H43N5O9/c1-23(2)34(45)41-37-40-33-30(35(46)42-37)39-22-43(33)36-32(50-20-19-47-3)31(44)29(52-36)21-51-38(24-9-7-6-8-10-24,25-11-15-27(48-4)16-12-25)26-13-17-28(49-5)18-14-26/h6-18,22-23,29,31-32,36,44H,19-21H2,1-5H3,(H2,40,41,42,45,46)/t29-,31-,32-,36-/m1/s1

InChI key: InChIKey=XDLPRZLZAFJSMA-BEGXHNNXSA-N

SMILES: C(OC[C@H]1O[C@H]([C@H](OCCOC)[C@@H]1O)N2C3=C(N=C2)C(=O)N=C(NC(C(C)C)=O)N3)(C4=CC=C(OC)C=C4)(C5=CC=C(OC)C=C5)C6=CC=CC=C6

Synonyms:

• 20: PN: US20040005569 PAGE: 22 claimedsequence
• 22: PN: US20040014049 PAGE: 21 claimedsequence
• 26: PN: US20040006029 PAGE: 23 claimedsequence
• 5′-O-[Bis(4-methoxyphenyl)phenylmethyl]-2′-O-(2-methoxyethyl)-N-(2-methyl-1-oxopropyl)guanosine
• Guanosine, 5′-O-[bis(4-methoxyphenyl)phenylmethyl]-2′-O-(2-methoxyethyl)-N-(2-methyl-1-oxopropyl)-
• 26: PN: WO03106645 PAGE: 74 claimed sequence
• 19: PN: US20030211606 PAGE: 20 claimed sequence
• 23: PN: US20030198965 PAGE: 20 claimed sequence
• 97: PN: US20040005707PAGE: 21 claimed sequence
• 22: PN:US20040014047 PAGE: 21 claimed sequence
• 23:PN: US20040014050 PAGE: 21 claimed sequence
• 24: PN: US20040005565 PAGE: 17-22claimed sequence
• 25: PN:US20040014699 PAGE: 21 claimed sequence
• 22: PN: US20040006030 PAGE: 23 claimed sequence
• 24: PN: US20040014051 PAGE: 23 claimed sequence
• 23: PN: US20040005570PAGE: 21 claimed sequence

N2-ISOBUTYRYL-5 , O-(4,4 -DIMETHOXYTRITYL)-2 -O-(2

CAS: 251647-50-4

Formula: C₃₈H₄₃N₅O₉

Purity: 95%

Color and Shape: Solid

Molecular weight: 713.7761

Ref: IN-DA00C37K

5'-O-DMT-N2-Ibu-2'-OMe-G

CAS: 251647-50-4

5'-O-DMT-N2-Ibu-2'-OMe-G

Purity: 95%

Molecular weight: 713.78g/mol

Ref: 54-OR1007534

5'-O-DMT-N2-isobutyryl-2'-O-(2-methoxyethyl)guanosine

CAS: 251647-50-4

5'-O-DMT-N2-isobutyryl-2'-O-(2-methoxyethyl)guanosine is an antiviral monophosphate nucleoside. It has been shown to be a novel, high purity, and CAS No. 251647-50-4. It is a modified nucleic acid analogue that acts as an activator of ribonucleotide reductase and DNA polymerase. The anticancer activity of this product may be due to its ability to inhibit the synthesis of diphosphate nucleotides.

Formula: C₃₈H₄₃N₅O₉

Purity: Min. 98 Area-%

Color and Shape: White Powder

Molecular weight: 713.78 g/mol

Ref: 3D-ND31620

5'-O-[Bis(4-methoxyphenyl)phenylmethyl]-2'-O-(2-methoxyethyl)-N-(2-methyl-1-oxopropyl)guanosine

Controlled Product

CAS: 251647-50-4

Formula: C₃₈H₄₃N₅O₉

Color and Shape: Neat

Molecular weight: 713.79

Ref: TR-B490100